Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689

NCT00623194 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 1

Interventions

DRUG: insulin detemir
DRUG: insulin aspart

Sponsor

Novo Nordisk A/S